Treace Medical Concepts (TMCI) director receives 30,000 RSU equity award
Rhea-AI Filing Summary
Kiernan Jane E reported acquisition or exercise transactions in this Form 4 filing.
Treace Medical Concepts director Jane E. Kiernan received a new equity award in the form of restricted stock units (RSUs). The Form 4 shows a grant of 30,000 RSUs with no cash paid per unit, bringing her direct holdings to 93,949 shares of common stock, including these RSUs.
The RSUs will be 100% vested on the earlier of May 19, 2027 or the date of the 2027 annual stockholder meeting, as long as she continues serving the company through that date. She has also elected to defer delivery of the underlying shares until the earlier of a change in control of the company or her separation of service, so the grant is a long-term, service-based compensation award rather than an immediate share issuance.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 30,000 shares
Net Buy
1 txn
Insider
Kiernan Jane E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 93,949 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.
- F2. Includes 30,000 restricted stock units.
Key Figures
RSU grant size: 30,000 RSUs
Grant price: $0.00 per unit
Post-grant holdings: 93,949 shares
+1 more
4 metrics
RSU grant size
30,000 RSUs
Restricted stock units granted to director on May 19, 2026
Grant price
$0.00 per unit
RSU award issued as compensation, not purchased in market
Post-grant holdings
93,949 shares
Total common stock holdings after transaction, including 30,000 RSUs
RSU vesting date
May 19, 2027
100% vesting on this date or 2027 annual meeting, whichever is earlier
Key Terms
restricted stock units (RSUs), change in control, separation of service
3 terms
restricted stock units (RSUs) financial
"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
change in control financial
"until the earlier of a change in control or the Reporting Person's separation of service..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
separation of service financial
"until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Treace Medical Concepts (TMCI) director Jane E. Kiernan report on this Form 4?
Jane E. Kiernan reported receiving a grant of 30,000 restricted stock units (RSUs). These RSUs represent a form of stock-based compensation and will convert into shares of Treace Medical Concepts common stock upon future vesting and settlement, rather than an immediate open-market purchase.
When do Jane E. Kiernan’s 30,000 Treace Medical Concepts (TMCI) RSUs vest?
The 30,000 RSUs vest 100% on the earlier of May 19, 2027 or the date of Treace Medical Concepts’ 2027 annual stockholder meeting. Vesting is conditioned on Kiernan continuing to provide service to the company through the applicable vesting date.
How will the Treace Medical Concepts (TMCI) RSUs reported by Jane E. Kiernan be settled?
Each RSU entitles Jane E. Kiernan to receive one share of Treace Medical Concepts common stock upon vesting. She elected to defer receipt of the shares until the earlier of a change in control of the company or her separation of service from Treace.
What conditions affect Jane E. Kiernan’s Treace Medical Concepts (TMCI) RSU award?
The RSUs require continued service to Treace Medical Concepts through vesting, which occurs in 2027 based on time or the annual meeting date. Additionally, she has chosen to defer settlement until either a change in control or her separation of service from the company.